Our internal development program is focused on the development of mRNA based prophylactic vaccines and therapeutics. To further explore the potential of our delivery technology 20Med is interested in discussing collaborations for these and other applications of our delivery platform. Strategic alliances are of interest based on access to 20Med's proprietary nanoparticle technology or co-development of vaccines and therapeutics.
Read more about how we apply our innovative nanotechnology here.
Please contact us at BD@20medtx.com for any partnership inquiries or business opportunities.